Work

3097 Safety and efficacy of first-line nivolumab (NIVO) and ipilimumab (IPI) in non-small cell lung cancer (NSCLC)

Year: 2015

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(16)31738-5

Authors: M.D. Hellmann, N. Rizvi, S.N. Gettinger, J. Goldman, L.Q. Chow, R. Juergens, H. Borghaei, J. Brahmer, Y. Shen, C.T. Harbison, F. Nathan, N.E. Ready, S.J. Antonia

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2517958744

FWCI: 1.165

Cites:

Cited by: 8

Related to: 10